03:12 AM EDT, 05/16/2024 (MT Newswires) -- Sean Maduck, President, Corcept Endocrinology, on May 13, 2024, sold 50,000 shares in Corcept Therapeutics ( CORT ) for $1,400,000. Following the Form 4 filing with the SEC, Maduck has control over a total of 105,222 shares of the company, with 85,222 shares held directly and 20,000 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1088856/000095017024060767/xslF345X03/ownership.xml
Price: 27.16, Change: -0.67, Percent Change: -2.41